reference/35467161

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35467161

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1276
issn	0006-4971 1528-0020
issueIdentifier	11
pageRange	1265-1276
publicationName	Blood
startingPage	1265
bibliographicCitation	Daver NG, Dail M, Garcia JS, Jonas BA, Yee KWL, Kelly KR, Vey N, Assouline S, Roboz GJ, Paolini S, Pollyea DA, Tafuri A, Brandwein JM, Pigneux A, Powell BL, Fenaux P, Olin RL, Visani G, Martinelli G, Onishi M, Wang J, Huang W, Green C, Ott MG, Hong WJ, Konopleva MY, Andreeff M. Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial. Blood. 2023 Mar 16;141(11):1265–76. PMID: 36265087; PMCID: PMC10651777.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e656f1def0bc9ef41f4569b965d2bb8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5645-0364 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a313f4f174fd19de833a0427551e14cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7027-040X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf017b360cf0bab7c1e071d83c68fe7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9095-8789 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7103-373X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8cdb97e62ae0f16995c6784026efd22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5903-721X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_006c566c4888e117a681461adb4a60a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6100db721db112649587e3ad575b872 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0384-3658 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1144-1958 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de40cb3ba42f806092ddc7c702ed907e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26949a5d936f8c483ab8eefa4a3871e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2572-9952 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6519-4860 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98a6eed69ebfd020dc9f1362d2d1b07c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9347-2212 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4921-5809 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e67b3864c8c6552b314bb8313db70d12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0134-4927 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cecb9b4936137d9fd461b3123c0f884 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3275-4021 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e71abc9e193c776d845b5fcf9c416d8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_651dad39ecbc193e208334775cae8004 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2118-6302
date	2023-03-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36265087 https://doi.org/10.1182/blood.2022016362 https://pubmed.ncbi.nlm.nih.gov/PMC10651777
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/1528-0020 https://portal.issn.org/resource/ISSN/0006-4971
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
discusses	http://id.nlm.nih.gov/mesh/M0028488 http://id.nlm.nih.gov/mesh/M0215816 http://id.nlm.nih.gov/mesh/M0592199 http://id.nlm.nih.gov/mesh/M000614617 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015470Q000235 http://id.nlm.nih.gov/mesh/D015470Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019086Q000009 http://id.nlm.nih.gov/mesh/D050676
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a03cbeca561fb1c14c97da4488860cbe http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_856e5d7a5833008375e9eecad638582f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53358942 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8124 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c09812e6766ef2f1e11efd56052399b5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_281c3deab424c97785a96e0444a0943e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7e4d19766b8958e96da36c9f9cf8a76 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b1179ffc80d13c0812f905e9c7e285da http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24085

Showing number of triples: 1 to 77 of 77.